Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > 🌟 Hello from PCR London Valves! 🌟Angiopro GmbH ✈️Buckle UP
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by jopatcloon Nov 25, 2024 8:45am
27 Views
Post# 36328702

RE:RE:🌟 Hello from PCR London Valves! 🌟Angiopro GmbH ✈️Buckle UP

RE:RE:🌟 Hello from PCR London Valves! 🌟Angiopro GmbH ✈️Buckle UP
Maybe some news from Bart soon? This week!!!
Excuse better in English
 

Bart Hendriks • 3e et +

Top Motivational Speaker | Author | CEO & Mentor | Inspiring Growth & Transformative Leadership Advisor
 
 
Congrats!


 
Danke HerzzentrumKln und das tolle
Team von Prof. Baldus und Dr. Matti Adam.

Die ersten SavvyWire Cases in NRW!

Ich bin gespannt welches Bundesland als nchstes kommt!
Another Milestone for SavvyWire in Germany!

After last week’s first SavvyWire case in Germany, we’re thrilled to announce that this week saw the first SavvyWire case in Nordrhein-Westfalen!

A huge congratulations to the amazing team at Uniklinik Kln HerzzentrumKln led by Dr. Matti Adam for successfully showcasing the benefits of the all-in-one system, combining hemodynamic monitoring, rapid pacing, and guidewire functionality into a single, streamlined tool.

With every step, SavvyWire is transforming TAVI procedures—simplifying workflows and improving outcomes for patients across Germany.

Bart Hendriks • 3e et +

Top Motivational Speaker | Author | CEO & Mentor | Inspiring Growth & Transformative Leadership Advisor
 
 
Congrats!


 
Danke HerzzentrumKln und das tolle
Team von Prof. Baldus und Dr. Matti Adam.

Die ersten SavvyWire Cases in NRW!

Ich bin gespannt welches Bundesland als nchstes kommt!
Another Milestone for SavvyWire in Germany!

After last week’s first SavvyWire case in Germany, we’re thrilled to announce that this week saw the first SavvyWire case in Nordrhein-Westfalen!

A huge congratulations to the amazing team at Uniklinik Kln HerzzentrumKln led by Dr. Matti Adam for successfully showcasing the benefits of the all-in-one system, combining hemodynamic monitoring, rapid pacing, and guidewire functionality into a single, streamlined tool.

With every step, SavvyWire is transforming TAVI procedures—simplifying workflows and improving outcomes for patients across Germany.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities